Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-18 to 2024-02-28
Current total value of award: $79.33
Description: 8510454686!MIDAZOLAM HYDROCHLO